Spiradoline

N/A

Report date: 2022/06/30 14:39:14
NME

Base Information

Drug NameSpiradoline
Drug Alias Name螺拉多林spiradolineespiradolina螺多林螺朵林 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKappa opioid receptor agonistsSodium channels blockersPotassium channel antagonists
TargetsKappa opioid receptorSodium channelsPotassium channel
Therapy Area/IndicationsBipolar DisorderPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsBipolar DisorderPain

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG